Glyphic Biotechnologies

Glyphic Biotechnologies is a biotechnology company based in Berkeley, California, pioneering next-generation protein sequencing technology. Their core innovation, Protein Sequencing by Expansion (ProSE™), enables massively parallel, single-molecule proteome sequencing with the ability to accurately discriminate all 20 amino acids and post-translational modifications. This breakthrough platform is designed to provide unprecedented precision, scalability, and accessibility in proteomics, aiming to unlock deeper biological insights and accelerate the development of critical new therapies. Founded in 2021, Glyphic is recognized for its strong intellectual property portfolio and its mission to fundamentally rewrite the rules of proteomics, positioning protein sequencing as a defining technology of the 21st century.

People interested in working at Glyphic Biotechnologies will find a dynamic, mission-driven environment focused on solving complex and meaningful scientific challenges. The company values exceptional talent motivated by innovation and offers opportunities to contribute to category-defining technology in life sciences. Employees are part of a close-knit, intellectually diverse team, collaborating across disciplines such as chemistry, data science, and platform development. Glyphic’s culture emphasizes technical excellence, proactive problem-solving, and the chance to shape the future of biological research and healthcare, making it an exciting workplace for those passionate about advancing science and technology.